Cargando…
MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer
The mammalian STE 20-like protein kinase 4 (MST4) gene is highly expressed in several cancer types, but little is known about the role of MST4 in breast cancer, and the function of MST4 during epithelial-mesenchymal transition (EMT) has not been fully elucidated. Here we report that overexpression o...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777386/ https://www.ncbi.nlm.nih.gov/pubmed/36552828 http://dx.doi.org/10.3390/cells11244057 |
_version_ | 1784856090858487808 |
---|---|
author | Arora, Ritu Kim, Jin-Hwan Getu, Ayechew A. Angajala, Anusha Chen, Yih-Lin Wang, Bin Kahn, Andrea G. Chen, Hong Reshi, Latif Lu, Jianrong Zhang, Wenling Zhou, Ming Tan, Ming |
author_facet | Arora, Ritu Kim, Jin-Hwan Getu, Ayechew A. Angajala, Anusha Chen, Yih-Lin Wang, Bin Kahn, Andrea G. Chen, Hong Reshi, Latif Lu, Jianrong Zhang, Wenling Zhou, Ming Tan, Ming |
author_sort | Arora, Ritu |
collection | PubMed |
description | The mammalian STE 20-like protein kinase 4 (MST4) gene is highly expressed in several cancer types, but little is known about the role of MST4 in breast cancer, and the function of MST4 during epithelial-mesenchymal transition (EMT) has not been fully elucidated. Here we report that overexpression of MST4 in breast cancer results in enhanced cell growth, migration, and invasion, whereas inhibition of MST4 expression significantly attenuates these properties. Further study shows that MST4 promotes EMT by activating Akt and its downstream signaling molecules such as E-cadherin/N-cadherin, Snail, and Slug. MST4 also activates AKT and its downstream pro-survival pathway. Furthermore, by analyzing breast cancer patient tissue microarray and silicon datasets, we found that MST4 expression is much higher in breast tumor tissue compared to normal tissue, and significantly correlates with cancer stage, lymph node metastasis and a poor overall survival rate (p < 0.05). Taken together, our findings demonstrate the oncogenic potential of MST4 in breast cancer, highlighting its role in cancer cell proliferation, migration/invasion, survival, and EMT, suggesting a possibility that MST4 may serve as a novel therapeutic target for breast cancer. |
format | Online Article Text |
id | pubmed-9777386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97773862022-12-23 MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer Arora, Ritu Kim, Jin-Hwan Getu, Ayechew A. Angajala, Anusha Chen, Yih-Lin Wang, Bin Kahn, Andrea G. Chen, Hong Reshi, Latif Lu, Jianrong Zhang, Wenling Zhou, Ming Tan, Ming Cells Article The mammalian STE 20-like protein kinase 4 (MST4) gene is highly expressed in several cancer types, but little is known about the role of MST4 in breast cancer, and the function of MST4 during epithelial-mesenchymal transition (EMT) has not been fully elucidated. Here we report that overexpression of MST4 in breast cancer results in enhanced cell growth, migration, and invasion, whereas inhibition of MST4 expression significantly attenuates these properties. Further study shows that MST4 promotes EMT by activating Akt and its downstream signaling molecules such as E-cadherin/N-cadherin, Snail, and Slug. MST4 also activates AKT and its downstream pro-survival pathway. Furthermore, by analyzing breast cancer patient tissue microarray and silicon datasets, we found that MST4 expression is much higher in breast tumor tissue compared to normal tissue, and significantly correlates with cancer stage, lymph node metastasis and a poor overall survival rate (p < 0.05). Taken together, our findings demonstrate the oncogenic potential of MST4 in breast cancer, highlighting its role in cancer cell proliferation, migration/invasion, survival, and EMT, suggesting a possibility that MST4 may serve as a novel therapeutic target for breast cancer. MDPI 2022-12-15 /pmc/articles/PMC9777386/ /pubmed/36552828 http://dx.doi.org/10.3390/cells11244057 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Arora, Ritu Kim, Jin-Hwan Getu, Ayechew A. Angajala, Anusha Chen, Yih-Lin Wang, Bin Kahn, Andrea G. Chen, Hong Reshi, Latif Lu, Jianrong Zhang, Wenling Zhou, Ming Tan, Ming MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer |
title | MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer |
title_full | MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer |
title_fullStr | MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer |
title_full_unstemmed | MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer |
title_short | MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer |
title_sort | mst4: a potential oncogene and therapeutic target in breast cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777386/ https://www.ncbi.nlm.nih.gov/pubmed/36552828 http://dx.doi.org/10.3390/cells11244057 |
work_keys_str_mv | AT aroraritu mst4apotentialoncogeneandtherapeutictargetinbreastcancer AT kimjinhwan mst4apotentialoncogeneandtherapeutictargetinbreastcancer AT getuayechewa mst4apotentialoncogeneandtherapeutictargetinbreastcancer AT angajalaanusha mst4apotentialoncogeneandtherapeutictargetinbreastcancer AT chenyihlin mst4apotentialoncogeneandtherapeutictargetinbreastcancer AT wangbin mst4apotentialoncogeneandtherapeutictargetinbreastcancer AT kahnandreag mst4apotentialoncogeneandtherapeutictargetinbreastcancer AT chenhong mst4apotentialoncogeneandtherapeutictargetinbreastcancer AT reshilatif mst4apotentialoncogeneandtherapeutictargetinbreastcancer AT lujianrong mst4apotentialoncogeneandtherapeutictargetinbreastcancer AT zhangwenling mst4apotentialoncogeneandtherapeutictargetinbreastcancer AT zhouming mst4apotentialoncogeneandtherapeutictargetinbreastcancer AT tanming mst4apotentialoncogeneandtherapeutictargetinbreastcancer |